Variant report
Variant | nsv524993 |
---|---|
Chromosome Location | chr9:9327159-9330772 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2184082 | chr9:9327159-9327160 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs149504445 | chr9:9327221-9327222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369063397 | chr9:9327225-9327226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543361800 | chr9:9327264-9327265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144075226 | chr9:9327275-9327276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182642635 | chr9:9327278-9327279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34649992 | chr9:9327297-9327298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2039417 | chr9:9327309-9327310 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs75909672 | chr9:9327326-9327327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114439235 | chr9:9327336-9327337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575856402 | chr9:9327367-9327368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185720253 | chr9:9327401-9327402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536607678 | chr9:9327410-9327411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373893778 | chr9:9327452-9327453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190578533 | chr9:9327487-9327488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78633813 | chr9:9327490-9327491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565063987 | chr9:9327499-9327500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370831641 | chr9:9327511-9327512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2039416 | chr9:9327530-9327531 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs375760869 | chr9:9327554-9327555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183863880 | chr9:9327561-9327562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188808820 | chr9:9327576-9327577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76325158 | chr9:9327585-9327586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144294971 | chr9:9327614-9327615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs193292778 | chr9:9327629-9327630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115239117 | chr9:9327648-9327649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182557991 | chr9:9327658-9327659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4143735 | chr9:9327668-9327669 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs532750407 | chr9:9327687-9327688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551204113 | chr9:9327694-9327695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569337775 | chr9:9327700-9327701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146047859 | chr9:9327725-9327726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554793950 | chr9:9327737-9327738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373699776 | chr9:9327748-9327749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140019409 | chr9:9327786-9327787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115969608 | chr9:9327787-9327788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576726523 | chr9:9327807-9327808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142297453 | chr9:9327813-9327814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555956900 | chr9:9327817-9327818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533849022 | chr9:9327819-9327820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574170106 | chr9:9327839-9327840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532645882 | chr9:9327844-9327845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541504687 | chr9:9327864-9327865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35650113 | chr9:9327905-9327906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs57099554 | chr9:9327920-9327921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186902742 | chr9:9327935-9327936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527269779 | chr9:9327984-9327985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113655370 | chr9:9327985-9327986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140634870 | chr9:9328006-9328007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs573193202 | chr9:9328015-9328016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9326000-9327600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:9326600-9327200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr9:9327000-9327200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr9:9327200-9331400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr9:9327200-9331600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr9:9327600-9329800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr9:9329600-9330400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr9:9329600-9331800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr9:9329800-9330000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr9:9329800-9330200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr9:9329800-9330200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr9:9329800-9330600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr9:9329800-9333400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr9:9330000-9330200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr9:9330200-9331000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
16 | chr9:9330200-9332200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
17 | chr9:9330200-9335800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
18 | chr9:9330400-9330800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
19 | chr9:9330600-9331000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |